Analjit Singh appointed non-executive Chairman of Max Financial Services

New Delhi: Max Financial Services, which houses the life insurance business of the $3-billion Max Group, has named its sponsor and founding shareholder Analjit Singh as nonexecutive chairman of the company in a filing to stock exchanges on Monday.

Singh said his appointment on the board was in consultation with current chairman Naina Lal Kidwai, who felt that as the ‘principal sponsor’ of the company he would be able to expedite decision-making. Kidwai will now continue in her role as an independent non-executive director of the company.

“I am heavily committed to India, to my businesses and my family,” Singh told ET, refuting what he termed ‘rhetoric’ about him giving up on his home turf.

The Max Group founder also ruled out speculation pertaining to his plans to exit the life insurance venture. “We are not going to exit the business. I will remain the single-largest principal sponsor,” he said.

Singh will take a four-point plan to the board of the financial services company on Friday to strengthen the life insurance business with a focus on building its proprietary distribution channels, he told ET.

Max Life Insurance Company is the largest non-bank private life insurer in India and contributes over two-thirds of Max Group’s revenues.

The company was separated as part of a demerger process involving erstwhile Max India, following which it became a subsidiary of the listed Max Financial Services.

Max India and Max Ventures and Industries are two other listed entities that resulted from the demerger. The former houses the group’s hospitals business and its health insurance joint venture with Britain’s Bupa, while the latter is the holding company for the packaging and real estate interests of the group.

Japan’s Mitsui Sumitomo Insurance is an investor in Max Life Insurance Company.

The group recorded consolidated revenues of Rs 19,151 crore in the year to March 2018, the company stated in its exchange filings. It employs 24,500 people.

  • Related Posts

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry

    Chinese ‘Made in India’ Fakes brazening out with Impunity in Here too New Delhi: Chinese slur on AI Expo, thanks to Galgotia fiasco, has hit a raw nerve in domestic…

    Innovation & Biomedical Skill Centre (IBSC) is transforming Biomedical & Medical Device Workforce Scenario

    Landmark Industry-Academia Meet in AMTZ Visakhapatnam: Andhra Pradesh MedTech Zone (AMTZ), India’s leading MedTech ecosystem, hosted a landmark Industry–Academia Meet to commemorate eight transformative years of the Innovation and Biomedical…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

    Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

    Ayush Ministry Busts Illegal Ayurvedic Drug Factory in Dehradun: Over Rs 1 Crore Cash, Fake Medicines Seized in Major Raid

    Ayush Ministry Busts Illegal Ayurvedic Drug Factory in Dehradun: Over Rs 1 Crore Cash, Fake Medicines Seized in Major Raid

    Maha govt seeks ₹26.5 crore for state-wide drug tracking system amid spurious medicine crackdown

    Maha govt seeks ₹26.5 crore for state-wide drug tracking system amid spurious medicine crackdown

    Punjab and Haryana HC refuses bail to pharma owner in Rs 600 crore drugs diversion case

    Punjab and Haryana HC refuses bail to pharma owner in Rs 600 crore drugs diversion case

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry